col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


106 Results       Page 1

 [1] 
Elsevier: The Lancet Gastroenterology & Hepatology
  original article Date Title Authors   All Authors
1 [GO] 2023―Oct―06 Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease Joshua Quan, Ante Markovinović, Lindsay Hracs, Christopher Ma, Remo Panaccione, Gilaad G Kaplan, et al. (+23)
2 [GO] 2023―Apr―06 Effect of the COVID-19 pandemic on endoscopic surveillance in Lynch syndrome in the Netherlands Elsa L S A van Liere, Nanne K H de Boer, Ezra A Parsan, Monique E van Leerdam, Dewkoemar Ramsoekh
3 [GO] 2023―Mar―27 Status of HBV birth dose vaccination in Africa: the impact of COVID-19 and Gavi support on policy development Henry N Njuguna, Lindsey Hiebert, Neil Gupta, John W Ward
4 [GO] 2022―Dec―07 Has the COVID-19 pandemic changed endoscopy in the UK forever? Colin Rees, Ian Penman
5 [GO] 2022―Dec―05 Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study Zhigang Liu, Kaixing Le, Xin Zhou, James L Alexander, Simeng Lin, Claire Bewshea, et al. (+685)
6 [GO] 2022―Dec―05 Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD Antonius T Otten, Arno R Bourgonje, Marijn C Visschedijk
7 [GO] 2022―Oct―26 Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease Joshua Quan, Christopher Ma, Remo Panaccione, Lindsay Hracs, Nastaran Sharifi, Michelle Herauf, et al. (+14)
8 [GO] 2022―Sep―22 Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy Rania Selim, Judith Wellens, Stephanie Brann, Luke Marlow, Alex Adams, Jack J Satsangi
9 [GO] 2022―Sep―09 COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study James L Alexander, Zhigang Liu, Diana Muñoz Sandoval, Catherine Reynolds, Hajir Ibraheim, Sulak Anandabaskaran, et al. (+63)
10 [GO] 2022―May―21 Effect of the COVID-19 pandemic on procedure volumes in gastroenterology in the Netherlands Milan J Sonneveld, Sander Hardeman, Ernst J Kuipers, Wilmar de Graaf, Manon C W Spaander, Adriaan J van der Meer
11 [GO] 2022―May―14 Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens Petter Brodin, Moshe Arditi
12 [GO] 2022―May―09 COVID-19, childhood obesity, and NAFLD: colliding pandemics J Bernadette Moore
13 [GO] 2022―Apr―06 Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease Judith Wellens, Stephanie Brann, Alex Adams, Luke Marlow, James O Lindsay, Jack J Satsangi
14 [GO] 2022―Feb―23 Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada M Ellen Kuenzig, Jessica Widdifield, Sasha Bernatsky, Gilaad G Kaplan, Eric I Benchimol
15 [GO] 2022―Feb―04 Is the attenuated humoral response to COVID-19 vaccination in anti-TNF users relevant? Tarun Chhibba, Laura E Targownik
16 [GO] 2022―Feb―04 COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study James L Alexander, Nicholas A Kennedy, Hajir Ibraheim, Sulak Anandabaskaran, Aamir Saifuddin, Rocio Castro Seoane, et al. (+56)
17 [GO] 2021―Oct―14 SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy Rania Selim, Judith Wellens, Luke Marlow, Jack J Satsangi
18 [GO] 2021―Oct―13 Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease James L Alexander, Christian P Selinger, Nick Powell
19 [GO] 2021―Aug―12 Gastrointestinal services in India during COVID-19: does governance matter? Gargi S Sarode, Sachin C Sarode
20 [GO] 2021―Aug―12 Gastrointestinal services in India during COVID-19: does governance matter? - Authors' reply Arulraj Ramakrishnan, Aravindh Somasundaram, Sibithooran Karmegan, Paari Vijayaragavan, Ramesh Arasaradnam, Arun Palanisami, Nalla G Palanisami
21 [GO] 2021―Jul―28 The impact of COVID-19 on hepatitis services and civil society organisations Chris Wingrove, Cary James, Su Wang
22 [GO] 2021―Jul―08 Double trouble: a pandemic of obesity and COVID-19 Santosh Kumar K Y, Praveen Kumar R Bhat, Chandrashekar J Sorake
23 [GO] 2021―Jun―10 Alcohol-related harm during the COVID-19 pandemic The Lancet Gastroenterology & Hepatology
24 [GO] 2021―Jun―10 COVID-19: Colorectal cancer endoscopic surveillance in IBD Shahida Din, Daniel R Gaya, Ian D R Arnott
25 [GO] 2021―Jun―10 SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply James L Alexander, Nicholas A Kennedy, Charlie W Lees, Tariq Ahmad, Nick Powell
26 [GO] 2021―Jun―10 SARS-CoV-2 vaccination for patients with inflammatory bowel disease Hannah M Garcia Garrido, Martin P Grobusch, Geert R A M D'Haens, Abraham Goorhuis
27 [GO] 2021―Jun―09 Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination Osman Öcal, Stephanie-Susanne Stecher, Moritz Wildgruber
28 [GO] 2021―Jun―03 Management of gastrointestinal services in Tamil Nadu, India, during COVID-19 Arulraj Ramakrishnan, Aravindh Somasundaram, Nandhakumar Srinivasan, Sibithooran Karmegan, Sneha Madav, Krishnaveni Ramasamy, et al. (+5)
29 [GO] 2021―May―26 SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change? James L Alexander, Nick Powell
30 [GO] 2021―May―18 Impairment of colorectal cancer screening during the COVID-19 pandemic Luigi Laghi, Michela Cameletti, Clarissa Ferrari, Luigi Ricciardiello
31 [GO] 2021―May―18 Impairment of colorectal cancer screening during the COVID-19 pandemic Serhiy Semenov, Mohd Syafiq Ismail, Deirdre McNamara
32 [GO] 2021―May―18 Obesity: another ongoing pandemic The Lancet Gastroenterology & Hepatology
33 [GO] 2021―Apr―14 Effect of COVID-19 on the detection and management of colorectal cancer in England Jim P Tiernan, Michael M Davies
34 [GO] 2021―Apr―14 Effect of the COVID-19 pandemic on colorectal cancer care in France Sonia Priou, Guillaume Lamé, Gilles Chatellier, Christophe Tournigand, Emmanuelle Kempf
35 [GO] 2021―Mar―12 Predicting endoscopic activity recovery in England after COVID-19: a national analysis Kai Man Alexander Ho, Amitava Banerjee, Mark Lawler, Matthew D Rutter, Laurence B Lovat
36 [GO] 2021―Mar―11 Gastrointestinal sequelae 90 days after discharge for COVID-19 Jingrong Weng, Yichen Li, Jie Li, Lihan Shen, Lixin Zhu, Yufan Liang, et al. (+8)
37 [GO] 2021―Mar―11 The impact of SARS-CoV-2 variants on IBD management Jonathan P Segal, Aditi Kumar, Timothy Raine, Christopher A Lamb, Matthew J Brookes
38 [GO] 2021―Feb―11 COVID-19 hits viral hepatitis care for vulnerable populations Udani Samarasekera
39 [GO] 2021―Feb―11 Effect of COVID-19 on viral hepatitis services in Pakistan Zia Ul Mustafa, Chia Siang Kow, Syed Shahzad Hasan
40 [GO] 2021―Feb―09 SARS-CoV-2 vaccines and donor recruitment for FMT Gianluca Ianiro, Benjamin H Mullish, Christian Lodberg Hvas, Jonathan P Segal, Ed J Kuijper, Samuel P Costello, et al. (+21)
41 [GO] 2021―Feb―06 Implications of COVID-19 for patients with pre-existing digestive diseases: an update Ren Mao, Florian Rieder, Shomron Ben-Horin, Gilaad G Kaplan, Siew C Ng, Grace LH Wong, et al. (+2)
42 [GO] 2021―Feb―06 Acute severe ulcerative colitis: confronting an intensified stressor during the COVID-19 pandemic Bo Shen
43 [GO] 2021―Feb―06 Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study Shaji Sebastian, Gareth J Walker, Nicholas A Kennedy, Thomas E Conley, Kamal V Patel, Sreedhar Subramanian, et al. (+266)
44 [GO] 2021―Feb―06 Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study Lucie de Jonge, Joachim Worthington, Francine van Wifferen, Nicolas Iragorri, Elisabeth F P Peterse, Jie-Bin Lew, et al. (+7)
45 [GO] 2021―Jan―26 SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement James L Alexander, Gordon W Moran, Daniel R Gaya, Tim Raine, Ailsa Hart, Nicholas A Kennedy, et al. (+30)
46 [GO] 2021―Jan―15 Effect of COVID-19 on colorectal cancer care in England Clare Turnbull
47 [GO] 2021―Jan―15 Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study Eva J A Morris, Raphael Goldacre, Enti Spata, Marion Mafham, Paul J Finan, Jon Shelton, et al. (+15)
48 [GO] 2021―Jan―14 SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question Thomas Marjot, Gwilym J Webb, Alfred S Barritt, Pere Ginès, Ansgar W Lohse, Andrew M Moon, et al. (+3)
49 [GO] 2021―Jan―14 From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative Ajay M Verma, Anusha Patel, Sreedhar Subramanian, Philip J Smith
50 [GO] 2020―Dec―11 Resuming liver transplantation amid the COVID-19 pandemic Douglas Thorburn, Rhiannon Taylor, Julie Whitney, Anya Adair, Magdy Attia, Paul Gibbs, et al. (+9)
51 [GO] 2020―Oct―30 COVID-19 and liver transplantation: the jury is still out Oliver D Tavabie, Kushala W M Abeysekera, Thomas H Tranah, Jeremy S Nayagam, Varuna R Aluvihare
52 [GO] 2020―Oct―30 COVID-19 and liver transplantation: the jury is still out - Authors' reply Gwilym J Webb, Thomas Marjot, Eleanor Barnes, Alfred S Barritt, Andrew M Moon
53 [GO] 2020―Sep―21 COVID-19 vaccinations in patients with inflammatory bowel disease Aditi Kumar, Mohammed Nabil Quraishi, Jonathan P Segal, Tim Raine, Matthew J Brookes
54 [GO] 2020―Sep―18 SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19 Julie K Heimbach, Timucin Taner
55 [GO] 2020―Sep―18 Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa Maud Lemoine, Jin Un Kim, Gibril Ndow, Sulayman Bah, Karen Forrest, John Rwegasha, et al. (+6)
56 [GO] 2020―Sep―14 Clinical research: further COVID-19 collateral damage The Lancet Gastroenterology & Hepatology
57 [GO] 2020―Sep―14 IBD in the COVID-19 era: the value of international collaboration Erica J Brenner, Ryan C Ungaro, Jean-Frederic Colombel, Michael D Kappelman
58 [GO] 2020―Sep―02 COVID-19 as a barrier to attending for gastrointestinal endoscopy: weighing up the risks Colin J Rees, Matt D Rutter, Linda Sharp, Bu Hayee, James E East, Pradeep Bhandari, Ian Penman
59 [GO] 2020―Aug―29 Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study Gwilym J Webb, Thomas Marjot, Jonathan A Cook, Costica Aloman, Matthew J Armstrong, Erica J Brenner, et al. (+16)
60 [GO] 2020―Aug―17 Gastrointestinal and liver involvement in patients with COVID-19 Yongxing Xu, Pengei Liu, Jianwen Gu
61 [GO] 2020―Aug―17 Gastrointestinal and liver involvement in patients with COVID-19 Francisco J Barrera, José G González-González, René Rodríguez-Gutiérrez
62 [GO] 2020―Aug―17 Gastrointestinal and liver involvement in patients with COVID-19 - Authors' reply Yun Qiu, Jin-Shen He, Jin-Yu Tan, Si-Nan Lin, Ren Mao
63 [GO] 2020―Aug―05 Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder Jin Un Kim, Amir Majid, Rebekah Judge, Peter Crook, Rooshi Nathwani, Nowlan Selvapatt, et al. (+7)
64 [GO] 2020―Jul―30 Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic Massimiliano di Pietro, Ines Modolell, Maria O'Donovan, Catherine Price, Nastazja D Pilonis, Irene Debiram-Beecham, Rebecca C Fitzgerald
65 [GO] 2020―Jul―27 Eliminating viral hepatitis in the COVID-19 era: weighing challenge and opportunity The Lancet Gastroenterology & Hepatology
66 [GO] 2020―Jul―27 The impact of COVID-19 on hepatitis elimination Chris Wingrove, Lucy Ferrier, Cary James, Su Wang
67 [GO] 2020―Jul―16 Practice patterns of diagnostic upper gastrointestinal endoscopy during the initial COVID-19 outbreak in England Sheraz R Markar, Jonathan Clarke, James Kinross
68 [GO] 2020―Jul―13 Probiotics and COVID-19 Giancarlo Ceccarelli, Carolina Scagnolari, Francesco Pugliese, Claudio M Mastroianni, Gabriella d'Ettorre
69 [GO] 2020―Jul―13 Probiotics and COVID-19 Eric Giannoni, David Baud, Varvara Dimopoulou Agri, Glenn R Gibson, Gregor Reid
70 [GO] 2020―Jul―13 Probiotics and COVID-19 - Authors' reply Joyce W Y Mak, Francis K L Chan, Siew C Ng
71 [GO] 2020―Jun―29 Reduced rate of hospital admissions for liver-related morbidities during the initial COVID-19 outbreak Ahad Eshraghian, Alireza Taghavi, Saman Nikeghbalian, Seyed Ali Malek-Hosseini
72 [GO] 2020―Jun―23 Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Alex Thompson, Jidong Jia, Jinlin Hou, Cosmas Rinaldi Adithya Lesmana, et al. (+10)
73 [GO] 2020―Jun―19 Colorectal cancer screening in the USA in the wake of COVID-19 Aasma Shaukat, Timothy Church
74 [GO] 2020―Jun―15 Green endoscopy: a call for sustainability in the midst of COVID-19 James B Maurice, Keith Siau, Shaji Sebastian, Nitin Ahuja, Emma Wesley, William Stableforth, Bu'Hussain Hayee
75 [GO] 2020―Jun―15 Converging pandemics: implications of COVID-19 for the viral hepatitis response in sub-Saharan Africa Neil Gupta, Hailemichael Desalegn, Ponsiano Ocama, Karine Lacombe, Richard Njouom, Mary Afihene, et al. (+4)
76 [GO] 2020―Jun―15 Prevention of COVID-19 in patients with IBD - Authors' reply Nik Sheng Ding, Ping An, Weiguo Dong, Yijuan Ding
77 [GO] 2020―Jun―15 Drinking alone: COVID-19, lockdown, and alcohol-related harm The Lancet Gastroenterology & Hepatology
78 [GO] 2020―Jun―15 Wastewater monitoring of SARS-CoV-2: lessons from illicit drug policy Kari Lancaster, Tim Rhodes
79 [GO] 2020―Jun―11 Resuming liver transplantation amid the COVID-19 pandemic Hanns Lembach, Angus Hann, Siobhan C McKay, Hermien Hartog, Suresh Vasanth, Phillip El-Dalil, et al. (+13)
80 [GO] 2020―Jun―08 Faecal immunohistochemical testing in the COVID-19 era: balancing risk and costs Ramesh P Arasaradnam, Neeraj Bhala, Charles Evans, John Greenaway, Robert Logan, Ian Penman, et al. (+5)
81 [GO] 2020―Jun―06 Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective Aisling Barry, Smith Apisarnthanarax, Grainne M O'Kane, Gonzalo Sapisochin, Robert Beecroft, Riad Salem, et al. (+13)
82 [GO] 2020―Jun―04 COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registry Luca S Belli, Christophe Duvoux, Vincent Karam, Rene Adam, Valentin Cuervas-Mons, Luisa Pasulo, et al. (+11)
83 [GO] 2020―May―20 Prevention of COVID-19 in patients with IBD Jonathan P Segal, Mohammed Nabil Quraishi, Neeraj Bhala, Matthew James Brookes
84 [GO] 2020―May―20 Protecting patients with IBD during the COVID-19 pandemic Gionata Fiorino, Laurent Peyrin-Biroulet, Silvio Danese
85 [GO] 2020―May―13 Patterns of care for inflammatory bowel disease in China during the COVID-19 pandemic Yan Chen, Shurong Hu, Hao Wu, Francis A Farraye, Charles N Bernstein, Jing-Jing Zheng, et al. (+2)
86 [GO] 2020―May―13 Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey Ferdinando D'Amico, Jean-François Rahier, Salvo Leone, Laurent Peyrin-Biroulet, Silvio Danese
87 [GO] 2020―May―12 Implications of gastrointestinal manifestations of COVID-19 Lijing Yang, Lei Tu
88 [GO] 2020―May―12 Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis Ren Mao, Yun Qiu, Jin-Shen He, Jin-Yu Tan, Xue-Hua Li, Jie Liang, et al. (+7)
89 [GO] 2020―May―04 Resumption of daily services in a gastroenterology department in Guangzhou, China, in the wake of COVID-19 Jing Han, Liguo Zhu, Ying Wang, Zhirong Zeng, Shenghong Zhang
90 [GO] 2020―Apr―25 Determining risk factors for mortality in liver transplant patients with COVID-19 Gwilym J Webb, Andrew M Moon, Eleanor Barnes, A Sidney Barritt, Thomas Marjot
91 [GO] 2020―Apr―25 Probiotics and COVID-19: one size does not fit all Joyce W Y Mak, Francis K L Chan, Siew C Ng
92 [GO] 2020―Apr―22 Screening FMT donors during the COVID-19 pandemic: a protocol for stool SARS-CoV-2 viral quantification Siew C Ng, Francis K L Chan, Paul K S Chan
93 [GO] 2020―Apr―17 Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China Ping An, Mengyao Ji, Haixia Ren, Juan Su, Nik Sheng Ding, Jian Kang, et al. (+22)
94 [GO] 2020―Apr―16 Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period Marietta Iacucci, Rosanna Cannatelli, Nunzia Labarile, Ren Mao, Remo Panaccione, Silvio Danese, et al. (+3)
95 [GO] 2020―Apr―15 Enteric involvement in hospitalised patients with COVID-19 outside Wuhan Yunle Wan, Jie Li, Lihan Shen, Yifeng Zou, Linlin Hou, Lixin Zhu, et al. (+14)
96 [GO] 2020―Apr―09 COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy Sherrie Bhoori, Roberta Elisa Rossi, Davide Citterio, Vincenzo Mazzaferro
97 [GO] 2020―Apr―01 SARS-CoV-2 in wastewater: potential health risk, but also data source Willemijn Lodder, Ana Maria de Roda Husman
98 [GO] 2020―Mar―30 Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward Christopher A Green, Mohammed N Quraishi, Sahida Shabir, Naveen Sharma, Richard Hansen, Daniel R Gaya, et al. (+3)
99 [GO] 2020―Mar―25 Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak Fabiana Zingone, Edoardo Vincenzo Savarino
100 [GO] 2020―Mar―20 COVID-19 and the liver: little cause for concern Mansoor N Bangash, Jaimin Patel, Dhruv Parekh
101 [GO] 2020―Mar―20 Prolonged presence of SARS-CoV-2 viral RNA in faecal samples Yongjian Wu, Cheng Guo, Lantian Tang, Zhongsi Hong, Jianhui Zhou, Xin Dong, et al. (+11)
102 [GO] 2020―Mar―17 Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel Gianluca Ianiro, Benjamin H Mullish, Colleen R Kelly, Harry Sokol, Zain Kassam, Siew Ng, et al. (+10)
103 [GO] 2020―Mar―17 Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis Yong Xiao, Hong Pan, Qian She, Fen Wang, Mingkai Chen
104 [GO] 2020―Mar―12 Implications of COVID-19 for patients with pre-existing digestive diseases Ren Mao, Jie Liang, Jun Shen, Subrata Ghosh, Liang-Ru Zhu, Hong Yang, et al. (+2)
105 [GO] 2020―Mar―09 Liver injury in COVID-19: management and challenges Chao Zhang, Lei Shi, Fu-Sheng Wang
106 [GO] 2020―Feb―20 Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Charleen Yeo, Sanghvi Kaushal, Danson Yeo
 [1] 

106 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec